OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.
OcuTerra Therapeutics's investors include Robin Hood Ventures.
OcuTerra Therapeutics is headquartered in Boston, United States.
OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.
OcuTerra Therapeutics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OcuTerra Therapeutics — Funding & Investors." VCBacked, January 10, 2024, https://www.vcbacked.co/company/ocuterra-therapeutics. Accessed October 1, 2026.
VCBacked. (2024). OcuTerra Therapeutics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/ocuterra-therapeutics
{{cite web |title=OcuTerra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ocuterra-therapeutics |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated